Pephexia Therapeutics ApS
CVR 41319208 · Private limited company (ApS) · Active · High risk
Pephexia Therapeutics ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 5.9% over the next 12 months, which is 4.2 times the average for Danish companies. 6 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -19.7m and a net result of DKK -4.4m. CEO: Keld Fogtmann Fosgerau.
Bankruptcy risk for Pephexia Therapeutics ApS
4.2 × the average (1.41%) · higher risk than 93% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 41319208
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (6 years)
- Address
- c/o Keld Fosgerau, Nordre Fasanvej 215, 4.
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 72k
- Auditor
- PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 6 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -979.4% |
| Current ratio | 641% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -180k | DKK -2.1m |
| Net profit | DKK -4.4m | DKK -5.3m |
| Equity | DKK -19.7m | DKK -15.3m |
| Total assets | DKK 2.0m | DKK 5.9m |
| Cash | DKK 292k | – |
| Short-term debt | DKK 309k | – |
| Avg. employees | 4 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Eriksen Funch, Statsautoriseret Revisions aktie selskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 152 | ||
| 1 Jan 2024 – 31 Dec 2024 | 112 | ||
| 1 Jan 2023 – 31 Dec 2023 | 145 | ||
| 1 Jan 2022 – 31 Dec 2022 | 142 | ||
| 1 Jan 2021 – 31 Dec 2021 | 137 | ||
| 24 Apr 2020 – 31 Dec 2020 | 116 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Keld Fogtmann Fosgerau | Current | |
| Board | Mats Peter Blom | Current | |
| Board | Andrew Justin Stewart Coats | Current | |
| Board | Keld Fogtmann Fosgerau | Current | |
| Board | Anders Mørkeberg Hinsby | Current | |
| Board | Stefan Dietmar Anker | Current | |
| Board | Ricki Boye | Current | |
| Board | Keld Fogtmann Fosgerau | ||
| Board | Yann Albert André Colardelle | ||
| Owner (5%) | Andrew Justin Stewart Coats | Current | |
| Owner (50%) | Fogtmann Fosgerau Holding ApS | Current | |
| Owner (100%) | Fogtmann Fosgerau Holding ApS | ||
| Owner (67%) | Fogtmann Fosgerau Holding ApS | ||
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | Current | |
| Founder | Fogtmann Fosgerau Holding ApS | Current |
The CEOs' other companies
Keld Fogtmann Fosgerau – 2 other companies
- Fogtmann Fosgerau Holding ApS Active
- Fosgerau Consult ApS Active
Address history (2 moves)
| c/o Keld Fosgerau, Nordre Fasanvej 215, 4., 2000 Frederiksberg | |
| c/o Keld Fosgerau, Ole Maaløes Vej 3, 3., 2200 København N | |
| c/o Keld Fosgerau, Lyngholmvej 45, 2720 Vanløse |
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Adcendo ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Augustine Therapeutics Denmark ApS Active
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- BOOST Pharma ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- BioPhenyx ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
Similar companies in Frederiksberg
- Catalyst Vaccination A/S Frederiksberg
- RefuelBio ApS Frederiksberg
- BioMomentum Advisors ApS Frederiksberg
- Oak Mountain Consulting ApS Frederiksberg
- Biotinia ApS Frederiksberg
- Nordic BioVentures ApS Frederiksberg C
- Zevra Denmark A/S Frederiksberg
- BioPhenyx ApS Frederiksberg
- BioSpringbok ApS Frederiksberg
- Orbis Medicines ApS Frederiksberg
- Epoqe Pharma ApS Frederiksberg
- SJM IP ApS Frederiksberg C
Questions and answers about Pephexia Therapeutics ApS
Has Pephexia Therapeutics ApS gone bankrupt?
No, Pephexia Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Pephexia Therapeutics ApS?
Our model estimates a bankruptcy risk of 5.9% over the next 12 months (high risk), which is 4.2 times the average for Danish companies.
Who is the CEO of Pephexia Therapeutics ApS?
Keld Fogtmann Fosgerau is the CEO of Pephexia Therapeutics ApS.
Who is the auditor of Pephexia Therapeutics ApS?
Pephexia Therapeutics ApS most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
When was Pephexia Therapeutics ApS founded?
Pephexia Therapeutics ApS was founded on 24 April 2020.
What is the equity of Pephexia Therapeutics ApS?
Equity was DKK -19.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.